Literature DB >> 22172835

Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients.

D R Lee1, J M Kong, K I Cho, L Chan.   

Abstract

Low vitamin D levels prevalent in patients with chronic kidney disease have been reported to be associated with proteinuria, insulin resistance, and cardiovascular disease. Kidney transplant recipients are also susceptible to low vitamin D levels but their clinical significance is uncertain. This study investigated the prevalence and association of vitamin D insufficiency with proteinuria, insulin resistance, and cardiovascular parameters among 95 living donor kidney transplant recipients. Levels of 25-hydroxyvitamin D [25(OH)D] were stratified into an insufficient group [25(OH)D≤30 ng/mL; n=19] versus a normal group [25(OH)D>30 ng/mL; n=76]. Proteinuria (urinary protein-creatinine [P/C]≥0.2 mg/mg), insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]) and cardiovascular parameters were compared between groups. Twenty percent of subjects showed vitamin D insufficiency. Proteinuria was higher among the vitamin D insufficient than the normal group (47.4% vs 18.7%; P=.02). 25(OH)D levels inversely correlated with urinary P/C ratio and intact parathyroid hormone (I-PTH) levels (r=-.24, P=.02 and r=-.23, P=.02, respectively). No correlations were observed between 25(OH)D levels and HOMA-IR scores or cardiovascular parameters. On univariate analysis, proteinuria and i-PTH levels were independent predictors of vitamin D insufficiency (P<.01 and P=.03, respectively). Multivariate analysis demonstrated proteinuria to be a significant predictor of vitamin D insufficiency (odds ratio=4.526; P=.03). In conclusion, vitamin D insufficiency was common and significantly associated with proteinuria among kidney transplant recipients. Additional studies are needed to clarify the causal relationship of vitamin D insufficiency with proteinuria and to determine the role of vitamin D supplementation to attenuate the development of proteinuria.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172835     DOI: 10.1016/j.transproceed.2011.08.081

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Vitamin D deficiency aggravates ischemic acute kidney injury in rats.

Authors:  Ana Carolina de Bragança; Rildo A Volpini; Daniele Canale; Janaína G Gonçalves; Maria Heloisa M Shimizu; Talita R Sanches; Antonio C Seguro; Lúcia Andrade
Journal:  Physiol Rep       Date:  2015-03

2.  VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.

Authors:  Marie Courbebaisse; Corinne Alberti; Sandra Colas; Dominique Prié; Jean-Claude Souberbielle; Jean-Marc Treluyer; Eric Thervet
Journal:  Trials       Date:  2014-11-06       Impact factor: 2.279

3.  The Restoration of Vitamin D Levels Slows the Progression of Renal Ischemic Injury in Rats Previously Deficient in Vitamin D.

Authors:  Michele Santiago Dos Santos; Daniele Canale; Desiree Rita Denelle Bernardo; Maria Heloisa Massola Shimizu; Antonio Carlos Seguro; Rildo Aparecido Volpini; Ana Carolina de Bragança
Journal:  Front Med (Lausanne)       Date:  2021-04-01

4.  Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis.

Authors:  Caitlin C Hesketh; Greg A Knoll; Amber O Molnar; Anne Tsampalieros; Deborah L Zimmerman
Journal:  Syst Rev       Date:  2014-06-14

5.  Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury.

Authors:  Janaína Garcia Gonçalves; Ana Carolina de Bragança; Daniele Canale; Maria Heloisa Massola Shimizu; Talita Rojas Sanches; Rosa Maria Affonso Moysés; Lúcia Andrade; Antonio Carlos Seguro; Rildo Aparecido Volpini
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.